Thursday, May 16, 2024
spot_img
HomeNewsBusiness WireSpoke Sciences Acquires “SNAC” Drug Delivery Platform that Improves Bioavailability of Nutritional...

Spoke Sciences Acquires “SNAC” Drug Delivery Platform that Improves Bioavailability of Nutritional Supplements and Drugs

SEATTLE & BETHLEHEM, Pa.–(BUSINESS WIRE)–Spoke Sciences, Inc. (Spoke), an ingredient technology company developing innovative approaches to provide better, safer, and more reliable functional ingredients for foods, beverages, and cosmetics, has acquired a proven platform technology “SNAC” to expand its portfolio.


SNAC is an oral bioavailability enhancing excipient formally named N– (8- (2-hydroxybenzoyl) amino) caprylic acid. SNAC is already proven in two marketed products: a medical food combining SNAC and vitamin B-12; and an oral formulation of SNAC and the GLP-1 agonist semaglutide, a drug indicated for the treatment of type 2 diabetes.

SNAC was invented in the 1990s as an oral absorption enhancer that facilitated oral forms of a variety of water-soluble active ingredients previously only available by injection. Spoke has acquired from Seattle-based Receptor Life Sciences a patent portfolio covering the use of SNAC with certain non-water-soluble, e.g., “lipophilic” active ingredients. These lipophilic ingredients fall within “Class II” of active ingredients under the Biopharmaceutical Classification System (BCS). Because many pharmaceutical and naturally occurring compounds used in drugs, supplements and functional foods are BCS Class II, SNAC has tremendous potential.

“Spoke’s team, including Dr. Andrea Leone-Bay, the inventor of SNAC, is uniquely qualified to advance the science around SNAC and broaden its adoption,” said Greg Wesner, CEO of Spoke. “We are encouraged by SNAC’s proven ability to make simple oral dosage forms from drugs currently administered by injection. Spoke and its partners are eager to explore expanding uses for SNAC, adding convenience and patent life to important therapies.”

Terms of the agreement are not disclosed.

ABOUT SPOKE SCIENCES, INC.

Spoke Sciences is an ingredient technology company developing innovative approaches to provide better, safer, and more reliable functional ingredients to foods, beverages, and cosmetics. Spoke’s team of pharmaceutical and consumer products industry veterans bridges the best ideas from pharma and applies them in novel ways to improved consumer goods. For more information about Spoke Sciences, its patented technologies and exciting new consumer products, visit: www.spokesciences.com.

Contacts

Email contact: info@spokesciences.com

spot_img
RELATED ARTICLES
spot_img
spot_img
spot_img

Caribbean News

Growth of digital economy outperforms overall growth across OECD

PARIS, France - The information and communication technology (ICT) sector grew by an average of 6.3 percent between 2013 and 2023, about three times...

Global News

OECD Ministerial Council Meeting 2024

By Caribbean News Global PARIS, France - On the occasion of the 2024 OECD Ministerial Council Meeting, assembled on 2-3 May 2024 under the...